Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 110

Showing 26-50 of 110 citing articles:

Incidence and factors associated with SARS-CoV-2 infection and re-infection among people experiencing homelessness in Toronto, Canada: A prospective cohort study
Lucie Richard, Brooke Carter, Michael Liu, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319296-e0319296
Open Access
Alcohol consumption does not influence SARS-CoV-2 vaccine immunogenicity: A stop the spread Ottawa cohort analysis
Alicia Vachon, Alexa Keeshan, Yannick Galipeau, et al.
Vaccine (2025) Vol. 55, pp. 127034-127034
Open Access
Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model
Mariam Maltseva, Yannick Galipeau, Pauline S. McCluskie, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 351-351
Open Access
Patterns of SARS-CoV-2 seropositivity among essential workers in long term care and retirement homes in Ontario, Canada: A descriptive cross-sectional study
Christine Fahim, Siyi Wang, Nimitha Paul, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 3, pp. e0004294-e0004294
Open Access
Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse model
Tyler M. Renner, Matthew Stuible, Martín A. Rossotti, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Validation of new equipment for SARS-CoV-2 diagnosis in Ecuador: Detection of the virus and antibodies generated by disease and vaccines with one POC device
Stephany D. Villota, Eliana Veloz-Villavicencio, Santiago Garcia-Iturralde, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0321794-e0321794
Open Access
Cohort profile:Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e062187-e062187
Open Access | Times Cited: 16
Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens
François Cholette, Rissa Fabia, Angela Harris, et al.
Heliyon (2022) Vol. 8, Iss. 9, pp. e10270-e10270
Open Access | Times Cited: 15
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 7-16
Open Access | Times Cited: 15
Impact of the temperature on the interactions between common variants of the SARS-CoV-2 receptor binding domain and the human ACE2
Catherine Forest‐Nault, Izel Koyuturk, Jimmy Gaudreault, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition
Marc-André Limoges, A Quenum, Mohammad Mobarak H Chowdhury, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells
Sergio P. Alpuche-Lazcano, Matthew Stuible, Bassel Akache, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination
Alexa Keeshan, Yannick Galipeau, Aliisa Heiskanen, et al.
BMJ Open (2023) Vol. 13, Iss. 10, pp. e077714-e077714
Open Access | Times Cited: 7
Longitudinal Study on Seroprevalence and Immune Response to SARS-CoV-2 in a Population of Food and Retail Workers Through Transformation of ELISA Datasets
Abdelhadi Djaïleb, Megan-Faye Parker, Étienne Lavallée, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Large-scale validation of a plasmonic sensor for SARS-CoV-2 pseudo-neutralization with a cohort of food and retail workers
Julien Coutu, Pierre Ricard, Abdelhadi Djaïleb, et al.
Sensors & Diagnostics (2024) Vol. 3, Iss. 5, pp. 850-862
Open Access | Times Cited: 2
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study
Cecilia T. Costiniuk, Terry Lee, Joel Singer, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 447-447
Open Access | Times Cited: 2
Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination
Sharon Walmsley, Majid Nabipoor, Freda Qi, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 564-564
Open Access | Times Cited: 2
Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity
M. D’Souza, Alexa Keeshan, Christopher A. Gravel, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Longitudinal determination of seroprevalence and immune response to SARS-CoV-2 in a population of food and retail workers through decentralized testing and transformation of ELISA datasets
Abdelhadi Djaïleb, Megan-Faye Parker, Étienne Lavallée, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0314499-e0314499
Open Access | Times Cited: 2
Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays
Ashleigh R. Tuite, David N. Fisman, Kento T. Abe, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Humoral Responses in the Omicron Era Following 3-Dose SARS-CoV-2 Vaccine Series in Kidney Transplant Recipients
Caitríona M. McEvoy, Queenie Hu, Kento T. Abe, et al.
Transplantation Direct (2022) Vol. 9, Iss. 1, pp. e1401-e1401
Open Access | Times Cited: 11
Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
Mariam Maltseva, Yannick Galipeau, Tyler M. Renner, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 30-30
Open Access | Times Cited: 11
Incidence of SARS-CoV-2 Infection Among People Experiencing Homelessness in Toronto, Canada
Lucie Richard, Rosane Nisenbaum, Martin M. Brown, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e232774-e232774
Open Access | Times Cited: 6
COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series
Sharon Walmsley, Leah Szadkowski, Bradly G. Wouters, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106506-106506
Open Access | Times Cited: 6
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease
Kevin Yau, Alexandra Kurtesi, Freda Qi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6

Scroll to top